SCHEMBL559271

SCHEMBL559271

CCOC(=O)c1ccc(C(=O)O)cc1N

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
HSD17B10 Q99714 3/20 0.58
GAA P10253 5/20 0.54
MAPT P10636 3/20 0.54
HPGD P15428 3/20 0.54
KDM4E B2RXH2 2/20 0.54
GLA P06280 1/20 0.54
CASP1 P29466 1/20 0.54
CASP7 P55210 1/20 0.54
ATM Q13315 1/20 0.54
LMNA P02545 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
MAOA P21397 1/20 0.53
THRB P10828 1/20 0.50
HTT P42858 1/20 0.50
GFER P55789 1/20 0.50
PLEC Q15149 1/20 0.50
HRH3 Q9Y5N1 1/20 0.50
CA12 O43570 4/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2896486 0.90 ALDH1A1 (0.62) ALDH1A1HSD17B10GAAMAPTHPGD
SCHEMBL10597819 0.87 ALDH1A1 (0.58) ALDH1A1HSD17B10GAAMAPTHPGD
SCHEMBL11693736 0.87 LMNA (0.57) ALDH1A1HSD17B10GAAMAPTHPGD
SCHEMBL827667 0.85 TSHR (0.58) ALDH1A1HSD17B10KDM4ELMNACYP1A2
SCHEMBL9008367 0.83 TSHR (0.56) ALDH1A1HSD17B10KDM4ELMNACYP1A2
SCHEMBL6227901 0.83 HRH3 (0.52) ALDH1A1HSD17B10KDM4ELMNACYP1A2
SCHEMBL27547872 0.83 ALDH1A1 (0.54) ALDH1A1HSD17B10GAAMAPTHPGD
SCHEMBL29649164 0.83 ALDH1A1 (0.57) ALDH1A1HSD17B10GAAMAPTHPGD
SCHEMBL6044437 0.82 CA12 (0.68) ALDH1A1HSD17B10GAAMAPTKDM4E
SCHEMBL17694807 0.82 HRH3 (0.51) ALDH1A1HSD17B10GAAHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119101935-A Platinum-based self-supporting membrane catalyst, preparation method and application thereof in electrocatalytic hydrogen evolution 南通大学 2024-12-10 CN disclosed
CN-118026872-A 2-Amino dimethyl terephthalate eutectic and preparation method thereof 天津大学 2024-05-14 CN disclosed
CN-118026870-A 2-Amino dimethyl terephthalate-tetracyanobenzene eutectic crystal and preparation method and application thereof 天津大学 2024-05-14 CN disclosed
CN-115491051-A Preparation method and application of pigment yellow 155 德州学院 2022-12-20 CN disclosed
CN-106970509-B Toner, developer, toner cartridge, process cartridge, image forming apparatus and image forming method 富士施乐株式会社 2020-06-19 CN disclosed
EP-1724263-B1 BASIC AMINE COMPOUND AND USE THEREOF KUREHA CORP (JP) 2014-03-05 EP disclosed
US-20120035194-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS PFIZER INC. (US) 2012-02-09 US disclosed
US-7998978-B2 Substituted 2-amino-fused heterocyclic compounds PFIZER INC. (US) 2011-08-16 US disclosed
US-20110172212-A1 AMINE-BASED COMPOUND AND USE THEREOF KUREHA CORPORATION (JP) 2011-07-14 US disclosed
US-7968719-B2 Indazole derivatives as inhibitors of hormone sensitive lipase SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2011-06-28 US disclosed
US-5616778-A Modified form of bis-1,4-[2'-(2\",5\"-dimethoxycarbonylphenylazo)-3'-oxobutyramido]benzene and process for its synthesis SANDOZ LTD. (CH) 1997-04-01 US disclosed
US-5420145-A Antileukemia Shudo, Koichi (JP) 1995-05-30 US disclosed
EP-0617020-A1 Carboxylic acid derivatives having retinoic acid-like activity Shudo, Koichi, Prof. Dr. (JP) 1994-09-28 EP disclosed
US-5030247-A Mixtures of disazo compounds containing two phenyl diazo component radicals having one or two (C1-4 alkoxy)carbonyl groups and a bis-acetoacetamido-arylene coupling radical SANDOZ LTD. (CH) 1991-07-09 US disclosed
US-4379913-A Compositions useful as internal antistatic additives for polymeric structures DIAMOND SHAMROCK CORPORATION (US) 1983-04-12 US disclosed
US-4222788-A Mixed pigment and process of preparing the same BASF FARBEN & FASERN AG (DE) 1980-09-16 US disclosed
US-4136033-A DIAZO COUPLERS SANDOZ LTD. (CH) 1979-01-23 US disclosed
US-4003886-A Tetracarboxylic acid ester substituted disazo pigments CIBA-GEIGY AG (CH) 1977-01-18 US disclosed
US-3997521-A PIGMENTS SANDOZ LTD. (CH) 1976-12-14 US disclosed
US-3985711-A Dicarboxylic compounds having 2,4-quinazolinedione rings and polyester resins derived therefrom INSTITUT FRANCAIS DU PETROLE, DES CARBURANTS ET LUBRIFIANTS ET ENTREPRISE DE RECHERCHES ET D'ACTIVITIES PETROLIERES ELF (FR) 1976-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035194-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS MAPK1, SLC5A1, ATF1 ALDH1A1 1098/4885HSD17B10 2447/4885GAA 2711/4885
US-20110172212-A1 AMINE-BASED COMPOUND AND USE THEREOF NR0B2, NR5A2, NR1D2 ALDH1A1 2045/4885HSD17B10 608/4885GAA 4793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.